Chronic kidney disease

Area of Science:

• Nephrology
• Cardiology
• Public Health

Background:

• Chronic kidney disease (CKD) affects 850 million individuals worldwide, with 4 million requiring kidney replacement therapy.
• CKD is projected to be the fifth leading cause of death globally by 2050.
• CKD significantly increases the risk of premature cardiovascular disease (CVD), often leading to death before kidney failure.

Purpose of the Study:

• To highlight the global burden of CKD and its association with CVD.
• To emphasize the importance of early CKD screening, diagnosis, and staging.
• To underscore the impact of recent therapeutic advancements in managing CKD and its complications.

Main Methods:

• Review of global prevalence data for CKD.
• Analysis of projected mortality trends related to CKD.
• Synthesis of findings from recent randomized trials on CKD treatments.
• Examination of the link between CKD and cardiovascular disease risk.

Main Results:

• CKD impacts a vast global population and is a growing cause of mortality.
• Most CKD patients face cardiovascular complications, often preceding kidney failure.
• Recent large randomized trials have introduced effective treatments to slow kidney function decline and mitigate cardiovascular risk.

Conclusions:

• Early identification and intervention are crucial for managing CKD.
• Clinician engagement in CKD management can reduce global complications and kidney failure.
• New therapeutic strategies offer significant potential to improve outcomes for individuals with CKD and reduce overall healthcare burden.